|Bid||0.00 x 1800|
|Ask||0.00 x 3000|
|Day's Range||11.72 - 12.36|
|52 Week Range||4.02 - 13.45|
|Beta (5Y Monthly)||1.23|
|PE Ratio (TTM)||N/A|
|Earnings Date||Mar 10, 2021 - Mar 15, 2021|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||13.83|
HACKENSACK, NJ / ACCESSWIRE / February 22, 2021 / Champions Oncology, Inc. (NASDAQ:CSBR) a leading global oncology technology solutions provider transforming drug discovery through innovative pharmacology, biomarker, and data platforms, is pleased to announce the appointment of Rob Brainin to its Board of Directors.
The worst result, after buying shares in a company (assuming no leverage), would be if you lose all the money you put...
HACKENSACK, NJ / ACCESSWIRE / January 19, 2021 / Champions Oncology, Inc. (NASDAQ:CSBR), a leading global oncology technology company that is transforming drug discovery and development through data-driven research strategies, announced today a partnership with Code Ocean to expand the functionality of its SaaS program, Lumin Bioinformatics.